The prevention of fragility fractures in patients with non-metastatic prostate cancer: a position statement by the international osteoporosis foundation

Oncotarget
Luisella CianferottiMaria Luisa Brandi

Abstract

Androgen deprivation therapy is commonly employed for the treatment of non-metastatic prostate cancer as primary or adjuvant treatment. The skeleton is greatly compromised in men with prostate cancer during androgen deprivation therapy because of the lack of androgens and estrogens, which are trophic factors for bone. Men receiving androgen deprivation therapy sustain variable degrees of bone loss with an increased risk of fragility fractures. Several bone antiresorptive agents have been tested in randomized controlled trials in these patients. Oral bisphosphonates, such as alendronate and risedronate, and intravenous bisphosphonates, such as pamidronate and zoledronic acid, have been shown to increase bone density and decrease the risk of fractures in men receiving androgen deprivation therapy. Denosumab, a fully monoclonal antibody that inhibits osteoclastic-mediated bone resorption, is also effective in increasing bone mineral density and reducing fracture rates in these patients. The assessment of fracture risk, T-score and/or the evaluation of prevalent fragility fractures are mandatory for the selection of patients who will benefit from antiresorptive therapy. In the future, new agents modulating bone turnover and skeleta...Continue Reading

References

Nov 15, 1984·The New England Journal of Medicine·UNKNOWN Leuprolide Study Group
Sep 9, 2000·The New England Journal of Medicine·E OrwollA Lombardi
Aug 15, 2001·The Journal of Clinical Endocrinology and Metabolism·S KhoslaW M O'Fallon
Sep 29, 2001·The New England Journal of Medicine·M R SmithJ S Finkelstein
Jan 4, 2003·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·E S OrwollG A Gaich
Nov 7, 2003·The Journal of Clinical Endocrinology and Metabolism·Luigi GennariRanuccio Nuti
May 5, 2004·Seminars in Oncology·Vasily J Assikis, Jonathan W Simons
Aug 24, 2004·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J-M KaufmanB H Mitlak
Jul 15, 2005·JAMA : the Journal of the American Medical Association·Nima SharifiWilliam L Dahut
Sep 29, 2005·The Journal of Clinical Endocrinology and Metabolism·Susan L GreenspanNeil M Resnick
Mar 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M Dror MichaelsonMatthew R Smith
Jun 8, 2007·Clinical Genitourinary Cancer·Ron S IsraeliLeo V Lacerna
Sep 20, 2007·The New England Journal of Medicine·Kenneth W LylesUNKNOWN HORIZON Recurrent Fracture Trial
Feb 23, 2008·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·B Dawson-HughesUNKNOWN National Osteoporosis Foundation Guide Committee
Apr 4, 2008·The New England Journal of Medicine·Peter R Ebeling
Aug 30, 2008·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J A KanisUNKNOWN National Osteoporosis Guideline Group
Sep 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susan L GreenspanNeil M Resnick
Oct 29, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fred SaadKathleen I Pritchard
Dec 4, 2008·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Steven BoonenPierre D Delmas
Feb 5, 2009·Critical Reviews in Eukaryotic Gene Expression·Sue A Brown, Theresa A Guise
May 27, 2009·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Ann E KearnsCharles L Loprinzi
Aug 13, 2009·The New England Journal of Medicine·Steven R CummingsUNKNOWN FREEDOM Trial
Aug 13, 2009·The New England Journal of Medicine·Matthew R SmithUNKNOWN Denosumab HALT Prostate Cancer Study Group
Oct 13, 2009·The Journal of Clinical Endocrinology and Metabolism·Sherri-Ann M Burnett-BowieBenjamin Z Leder
Jan 22, 2010·Journal of Cancer Survivorship : Research and Practice·Farhana HaseenMarie M Cantwell
Jun 18, 2010·The Journal of Clinical Endocrinology and Metabolism·Jane A CauleyUNKNOWN Osteoporotic Fractures in Men Study (MrOS) Research Group
Feb 15, 2011·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J WooP C Leung
Mar 25, 2011·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Claes OhlssonLiesbeth Vandenput
Aug 24, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles J Ryan, Donald J Tindall
Jan 10, 2012·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·K LippunerR Rizzoli
May 25, 2012·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Nathan K LebrasseurSundeep Khosla
Jun 23, 2012·The Journal of Clinical Endocrinology and Metabolism·Eric OrwollSteven Boonen

❮ Previous
Next ❯

Citations

Jun 27, 2018·Journal of the Endocrine Society·Pamela TaxelCatherine Van Poznak
Nov 27, 2018·Endocrine Reviews·Judith GebauerGeorg Brabant
Jan 29, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philip J SaylorJeff M Michalski
Jul 18, 2020·Clinical Journal of Oncology Nursing·Lawrence Drudge-CoatesBrian Tomlinson
May 3, 2019·European Journal of Endocrinology·Cristina Eller-VainicherIacopo Chiodini
Aug 1, 2020·Current Osteoporosis Reports·Emma O Billington, Ian R Reid
Jul 4, 2018·Frontiers in Endocrinology·Ushashi C DadwalUma Sankar
Jul 13, 2020·International Journal of Clinical Practice·Heather PayneJoe M O'Sullivan
Jul 13, 2019·The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutica·Tim Van den Wyngaert, Bertrand Tombal
Feb 6, 2020·Journal of Bone and Mineral Metabolism·Seiji FukumotoUNKNOWN Subcommittee for CTIBL in the JSBMR
May 3, 2021·Journal of Cranio-maxillo-facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery·Goknur Topaloglu YasanOsman Taha Koseoglu
Jun 9, 2021·Archives of Orthopaedic and Trauma Surgery·Tal Frenkel RutenbergShai Shemesh
Nov 18, 2018·Urologic Oncology·Nicholas Russell, Mathis Grossmann

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.